SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-208155
Filing Date
2017-06-20
Accepted
2017-06-20 16:03:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d397519d424b5.htm 424B5 401056
2 GRAPHIC g397519g85h57.jpg GRAPHIC 43168
  Complete submission text file 0001193125-17-208155.txt   461654
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218294 | Film No.: 17920900
SIC: 2836 Biological Products, (No Diagnostic Substances)